Health Legislation

The decree establishes the pharmaceutical policy in Burkina Faso. The Pharmaceutical Policy is a national planning framework that expresses the government's vision, goals, objectives and strategic interventions for the development of the pharmaceutical sector. The policy aims to improve access to quality healthcare products, available throughout the country at a cost adapted to the population's purchasing power.

This document provides for standard treatment guidelines and the essential medicines list.

The decree revises Niger's national list of essential medicines from 2009

This Act provides for the establishment of an independent Drug and Food Control Authority in South Sudan and provide an appropriate and effective independent regulatory mechanism to control and regulate the manufacture, supply, promotion, marketing, advertising, distribution and use of drugs, poisons, chemicals, cosmetics medical devices and food for human or animal use.

This Act regulates the conduct of clinical trials for medicinal products in Mauritius.

The Decree establishes the General Bases of the National Pharmaceutical Policy.

The law reinforces the fight against the use and consumption of tobacco and tobacco products in Burkina Faso. The scope of the law covers the industrial or supervised cultivation of tobacco, the manufacture, packaging, marketing and consumption of tobacco and tobacco products, and exposure to tobacco smoke.

This Law defines the legal provisions relating to medicines, medical devices, other health products and the practice of pharmacy in the Islamic Republic of Mauritania. This Law is published in a collection of other legislative acts and can be found on page 3 of the file.

The Diploma approves the Medicines Registration Manual. The purpose of the Manual is to (a) Standardize the procedures and activities relating to the registration of medicines; (b) Clarify the doubts that professionals have encountered when interpreting the Registration Regulations; (c) Support professionals in the field in carrying out their daily activities in a standardized way; (d) Support applicants in complying with registration and post-registration procedures; (e) to make the registration process an optimized and increasingly swift process. 

The purpose of the Regulation is to define the procedures for approving pharmaceutical products for human use in the member states of the West African Economic and Monetary Union.

The Decree sets out the conditions for manufacturing and importing contraceptive products into Burkina Faso.

This document establishes a National List of Essential Medicines in the Central African Republic.

This Proclamation regulates activities in respect of food, medicine, environmental health, health professionals, health and controllable health related institutions in the country.

This Act regulates the use, sale, manufacture, advertising and promotion of a tobacco product and provides for connected matters.

This decree defines the scope of the prohibition on smoking in public places or places open to the public, and specifies the powers of health police officers in enforcing the law on tobacco control. It also sets out the rules governing the liability of manufacturers and distributors of tobacco products in the event of damage caused by the consumption of these products.

This Act controls the production, manufacture, sale, labelling, advertising, promotion and sponsorship of tobacco products, provides for the Tobacco Control Board, regulates smoking in specified areas and connected purposes.

This Act amends the Medicines and Related Substances Control Act, 2003, so as to amend and delete certain definitions; provides for a period within which the Council must be appointed; provides for the appointment of chairpersons of committees established by the Council; amends provisions relating to the classification of medicines and other substances as scheduled substances; amends provisions relating to the manufacturing, packing and selling of specified Schedule 3 and specified Schedule 4 substances; deletes references to generic substitutions; substitutes references to Schedule 1, Schedule 2, Schedule 3 or Schedule 4 medicines by references to Schedule 1, Schedule 2, Schedule 3 or Schedule 4 substances; inserts provisions relating to the registration of premises engaged in the manufacturing of medicines; amends provisions relating to offences and penalties; amends provisions relating to the destruction of forfeited medicines, scheduled substances or other things; provides for the making of regulations in relation to medicines; amends provisions relating to the exclusion of medicines from the operation of the Act; amends the transitional provisions; amends provisions relating to the repeal and amendment of certain laws; and provides for matters incidental thereto.

This Act amends section 38 of the Pharmacy and Drugs Act of 2001.

This decree regulates the marketing authorization, registration, manufacture, import, export, marketing, donations and advertising of medicines for human use.

The document establishes the list of essential medicines in the Republic of Mali.